Reports Summarize Personalized Medicine Study Results from Capital Medical University (MAGI3 enhances sensitivity to sunitinib in renal cell carcinoma by suppressing the MAS/ERK axis and serves as a prognostic marker)

Prensa/medios de comunicación: !!!Research

Períodofeb. 27 2025

Cobertura de los medios

1

Cobertura de los medios

  • NombreReports Summarize Personalized Medicine Study Results from Capital Medical University (MAGI3 enhances sensitivity to sunitinib in renal cell carcinoma by suppressing the MAS/ERK axis and serves as a prognostic marker)
    Nombre/canal del medio de comunicaciónClinical Oncology Daily
    País/TerritorioEstados Unidos
    Fecha27/2/25
    PersonasYang Yang
Ver todos 1
Ver menos